R6/2 mice

A23 Skeletal muscle regeneration is altered in the r6/2 mouse model of Huntington’s disease
Rana Soylu-Kucharz, Sanzana Hoque, Valérie Allamand, Marie Sjögren, Kinga Gawlik, Naomi Franke, Madeleine Durbeej-Hjalt, Maria Björkqvist

Journal of Neurology, Neurosurgery & Psychiatry Sep 2022, 93 (Suppl 1) A8-A9; DOI: 10.1136/jnnp-2022-ehdn.23
I22 Intranasal administration of mesenchymal stem cells ameliorates the abnormal dopamine transmission system and inflammatory reaction in the R6/2 mouse model of huntington disease
Libo Yu-Taeger, Janice Stricker-Shaver, Katrin Arnold, Patrycja Bambynek-Dziuk, Arianna Novati, Elisabeth Singer, Fabian Claire, Janine Magg, Olaf Riess, Alexandra Stolzing, Lusine Danielyan, Hoa Huu Phuc Nguyen

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A96; DOI: 10.1136/jnnp-2018-EHDN.258
L22 Intranasal application of NPY and NPY13–36 ameliorate disease pathology in R6/2 mouse model of huntington’s disease
Oluwaseun Fatoba, Eugen Kloster, Carsten Saft, Ralf Gold, Larissa Arning, Gisa Ellrichmann

Journal of Neurology, Neurosurgery & Psychiatry Sep 2016, 87 (Suppl 1) A97-A98; DOI: 10.1136/jnnp-2016-314597.277

Main menu